NCT03794154View on ClinicalTrials.gov

A Study Of Duloxetine Hydrochloride Hard Gelatinous Capsule Compared To Cymbalta Under Fed Conditions

PHASE4WithdrawnINTERVENTIONAL

Timeline

Start Date

March 30, 2020

Primary Completion Date

June 5, 2020

Study Completion Date

June 5, 2020

Conditions

Healthy

Interventions

DRUG

Cymbalta capsule

Active Comparator: Cymbalta®- hard gelatinous capsule with delayed release microgranules ( Eli Lilly do Brasil Ltda) equivalent to 60 mg of duloxetine.

DRUG

Duloxetine hydrochloride capsule

Experimental Drug: Duloxetine hydrochloride - hard gelatinous capsule with delayed release microgranules (Pfizer S.R.L - Argentina.) equivalent to 60 mg of duloxetine.